Good Shingles Vaccine Sales Prompts GSK To Raise Profit Forecast
The sale of shingles vaccine of GlaxoSmithKline beat market expectations and the continued good performance of the company’s older medicines, including HIV treatments prompted the drug making company to raise its annual profit forecast for the second time this year. Following the announcement by the British drug maker about its expectations of profit for the…









